How Our IGF-1 Clinical Studies Compare To Others

What is the difference in the clinical testing that was done on our human growth hormone formula and the testing that was done on some other product's formulas? In the study that was done on our formulas the testing was done using patients with a known growth hormone deficiency. A growth hormone deficiency usually comes about due to the pituitary gland not producing and releasing human growth hormone as it should.

Our clinical testing was more of a challenge, yet our formulas did help these patient's pituitary glands to release more growth hormone.

If you look closely at the clinical studies of others you will notice that some of their patient's IGF-1 results were obtained after only one day of therapy, while the results of other patients in the same study were obtained after many months of therapy.

We have no explanation as to why their testing was carried out in this way, but it appears they reported the patient's highest IGF-1 result, whether that patient's IGF-1 level was highest after only one day of therapy, or after 6 months of therapy. Of course any test result obtained and reported after only one day of therapy could not possibly be an accurate result because the body did not have time to adjust and level off.

Also, I cannot imagine they would record an IGF-1 result obtained after only one day of therapy, and send that patient home after the first day. They obviously were hopeful the patient's IGF-1 level would increase even more as the therapy continued, so they obviously had the patient continue the therapy. By the fact they ended up reporting an IGF-1 result obtained after only one day of therapy we know the IGF-1 results they obtained after that first day must have been lower than the first day's result. This does not speak well for their formula, if in some patients it works on the first day, and then stops working.

Proper Clinical Testing- The Differences

The testing done on our formulas tested every patient the same amount of time, 5 months, using the same testing criteria and guidelines, which is the proper way of testing. The IGF-1 results obtained on the day the 5 months of therapy concluded were the results that were reported. We could not go back and report an IGF-1 result that was obtained at an earlier date if that result was higher than the end result, which seems to be what some who have reported clinical results have done. Please click the link below to look closely at the IGF-1 results of the other products that have been tested.

Some companies do their own clinical testing. Product testing should not be done by the owners of the formula or the product because they stand to gain financially if their formula shows positive clinical results.

Some companies who sell human growth hormone products will have various people, clinics, patients, etc., test their formulas using their own various methods and/or types of patients. Each group will be tested at a different place by different people in a different way and for a different time span than the other groups. Then the company will go through all the various data from the different sources and will combine the data and somehow come up with an average IGF-1 result to report. Patients undergoing clinical studies should all be tested the same way under the same exact guidelines and circumstances.

Lastly, some companies/sellers show what appears to be clinical studies on their web site, but they don't give the name of any doctors (where you can read their names), or the name of a facility where the study was suppose to have been done; there is obviously a reason for this. We give both the name of the doctors and the facility in which our clinical studies were carried out.

Other HGH brands with IGF-1 clinical studies

About proper IGF-1 clinical testing

False and misleading claims about clinical studies

Back to page 1: Our IGF-1 clinical studies

Results of our HGH 4 week benefits survey

ProBLEN HGH products